Envoy Medical Inc (COCH) Stock Price, Quote & News

Company Profile

Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy...

Industry: Medical Devices

Sector: Healthcare

Phone: 877 900 3277

Website: www.envoymedical.com

Address:

4875 White Bear Parkway, White Bear Lake, United States

Wintermelonjuice Nov. 20 at 2:49 PM

$COCH they should be looking for an international partner for markets outside the US.

0 · Reply

Wintermelonjuice Nov. 20 at 2:39 PM

$COCH few years ago, a biotech co focused on agri tech got some patents, stock price went from below a dollar to 60 dollars.

0 · Reply

Wintermelonjuice Nov. 20 at 2:30 PM

$COCH A critical patent for fully implanted hearing device.

1 · Reply

Yeueehehe Nov. 20 at 1:16 PM

$COCH what a dead stock

0 · Reply

BigPennyStockAlerts Nov. 20 at 1:07 PM

$COCH Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

0 · Reply

newsfile_corp Nov. 20 at 1:02 PM

https://nfne.ws/275251 $COCH @envoymedical #Chemicals #Biotechnology #HealthCare #Patent #NASDAQ #Investing

0 · Reply

Wintermelonjuice Nov. 20 at 11:58 AM

$COCH 2 criteria for a sp that can fly: fully funded phase 3 & good 6 months' efficacy data from 1st 10 patents. Cochlear implant market in the US is hugely underserved due to patients not comfortable with exusting models that are not fully implanted.

1 · Reply

Wintermelonjuice Nov. 20 at 3:18 AM

$COCH will 6 months' efficacy data for the first 10 patients be released?

0 · Reply

Wintermelonjuice Nov. 19 at 5:11 PM

$COCH one co-sponsor added on Nov 18.

1 · Reply

sleighbell Nov. 18 at 7:55 PM

$COCH These implants change peoples lives dramatically. This stock should be much higher in value, $5 if not $10. Looks like they will need to raise cash soon so expect a catalyst to bring in buyers. Maybe a short term momentum play then a longer term hold for the big payout.

1 · Reply

Envoy Medical Reports Third Quarter 2025 Financial and Operational Results

Nov 4, 2025, 8:00 AM EST - 16 days ago

Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

Oct 29, 2025, 8:00 AM EDT - 22 days ago

Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant

Oct 27, 2025, 8:00 AM EDT - 24 days ago

Envoy Medical Receives Positive Listing Determination from NASDAQ

Oct 9, 2025, 4:05 PM EDT - 5 weeks ago

Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 8, 2025, 7:00 AM EDT - 6 weeks ago

Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 7, 2025, 8:00 AM EDT - 6 weeks ago

Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 7, 2025, 8:00 AM EDT - 6 weeks ago

Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 1, 2025, 8:00 AM EDT - 7 weeks ago

Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th

Sep 25, 2025, 8:00 AM EDT - 2 months ago

Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 24, 2025, 8:00 AM EDT - 2 months ago

Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track

Sep 22, 2025, 8:00 AM EDT - 2 months ago

Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 19, 2025, 8:00 AM EDT - 2 months ago

Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology

Sep 10, 2025, 8:00 AM EDT - 2 months ago

Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments

Sep 9, 2025, 8:00 AM EDT - 2 months ago

Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology

Sep 8, 2025, 8:00 AM EDT - 2 months ago

Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025

Sep 3, 2025, 8:00 AM EDT - 2 months ago

Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant

Aug 26, 2025, 8:00 AM EDT - 3 months ago

Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board

Aug 20, 2025, 8:00 AM EDT - 3 months ago

Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology

Jul 31, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical Reports on Second Quarter 2025 Results

Jul 8, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical Expands Patent Portfolio with New Issuances in the United States

Jul 1, 2025, 8:00 AM EDT - 5 months ago

Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia

Jun 26, 2025, 8:00 AM EDT - 5 months ago

New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical

Jun 11, 2025, 8:30 AM EDT - 5 months ago

Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th

Jun 10, 2025, 8:30 AM EDT - 5 months ago

Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up

May 13, 2025, 9:15 AM EDT - 6 months ago

Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial

May 1, 2025, 4:30 PM EDT - 7 months ago

Envoy Medical Reports on First Quarter 2025 Results

Apr 22, 2025, 6:00 AM EDT - 7 months ago

EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap Companies

Mar 31, 2025, 9:15 AM EDT - 8 months ago

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 17, 2025, 9:25 AM EDT - 8 months ago

Hearing Device Coverage Clarification Act Reintroduced in House and Senate

Mar 12, 2025, 9:00 AM EDT - 9 months ago

Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

Mar 10, 2025, 9:00 AM EDT - 9 months ago

Envoy Medical to Participate in the 37th Annual ROTH Conference

Feb 24, 2025, 9:25 AM EST - 9 months ago

First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Feb 14, 2025, 9:15 AM EST - 9 months ago

Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

Dec 19, 2024, 9:00 AM EST - 1 year ago

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Nov 14, 2024, 8:38 AM EST - 1 year ago

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Nov 12, 2024, 9:25 AM EST - 1 year ago

Envoy Medical's Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Nov 8, 2024, 9:25 AM EST - 1 year ago

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Oct 23, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical to Present at the LD Micro Main Event XVII

Sep 23, 2024, 8:00 AM EDT - 1 year ago

Major Envoy Medical Investor Glen Taylor Discusses How Apple's AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company

Sep 16, 2024, 9:00 AM EDT - 1 year ago

Envoy Medical Awarded Patent for Recharge System used with Implantable Battery

Sep 12, 2024, 7:19 AM EDT - 1 year ago

Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying

HYLN SXTP

Aug 12, 2024, 8:34 AM EDT - 1 year ago

Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update

Jul 31, 2024, 8:00 AM EDT - 1 year ago

Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage

Jul 1, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Announces Inclusion in the Russell Microcap Index

Jun 11, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling

Jun 6, 2024, 9:00 AM EDT - 1 year ago

Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index

May 19, 2024, 4:45 AM EDT - 1 year ago

Envoy Medical Is Pursuing Filling A Hearing Industry Void

May 15, 2024, 4:05 PM EDT - 1 year ago

Envoy Medical Reports First Quarter 2024 Results

Wintermelonjuice Nov. 20 at 2:49 PM

$COCH they should be looking for an international partner for markets outside the US.

0 · Reply

Wintermelonjuice Nov. 20 at 2:39 PM

$COCH few years ago, a biotech co focused on agri tech got some patents, stock price went from below a dollar to 60 dollars.

0 · Reply

Wintermelonjuice Nov. 20 at 2:30 PM

$COCH A critical patent for fully implanted hearing device.

1 · Reply

Yeueehehe Nov. 20 at 1:16 PM

$COCH what a dead stock

0 · Reply

BigPennyStockAlerts Nov. 20 at 1:07 PM

$COCH Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

0 · Reply

newsfile_corp Nov. 20 at 1:02 PM

https://nfne.ws/275251 $COCH @envoymedical #Chemicals #Biotechnology #HealthCare #Patent #NASDAQ #Investing

0 · Reply

Wintermelonjuice Nov. 20 at 11:58 AM

1 · Reply

Wintermelonjuice Nov. 20 at 3:18 AM

$COCH will 6 months' efficacy data for the first 10 patients be released?

0 · Reply

Wintermelonjuice Nov. 19 at 5:11 PM

$COCH one co-sponsor added on Nov 18.

1 · Reply

sleighbell Nov. 18 at 7:55 PM

1 · Reply

makedatbread88 Nov. 18 at 7:37 PM

$COCH nicee ***FOLLOW ME for more winning calls!***

0 · Reply

Jedelzzz Nov. 18 at 7:35 PM

$LAES will follow $COCH

0 · Reply

BinaryLogic Nov. 18 at 7:06 PM

$COCH [Again] Keep in mind that investors are still getting a sizeable discount to institutional placements at $1.3. Review the trailing ER that I have posted, and see the progress this Company has made to this point. Oversold on the 1YR Daily and 3YR Weekly Charts, Undervalued and upside on a clear multiple from today (IMO). https://www.zacks.com/stock/research/COCH/price-target-stock-forecast

1 · Reply

A1DAYTRADER Nov. 18 at 6:40 PM

🚀 ACE TRADES 🤫🔥 $COCH [NASDAQ] Quick Take: Micro-cap hearing-health play — momentum forming on implant tech 🚀 📰 News: • ✅ FDA trial for Acclaim cochlear implant progressing • 💰 Raised $2.5M via ATM offering • 🛠 Expanding patent portfolio in implant tech 📊 Stats: Float: ~7.2M shares 💹 Bias: Bullish 🤫🔥

0 · Reply

HITK101 Nov. 18 at 6:39 PM

$COCH $LAES $ONDS $GRRR $WULF

0 · Reply

HITK101 Nov. 18 at 5:54 PM

$ONDS come to $LAES and $COCH

1 · Reply

HITK101 Nov. 18 at 5:41 PM

$VNDA come to $COCH abd $LAES

0 · Reply

HITK101 Nov. 18 at 5:39 PM

$COCH doing well $SCNX low float due for a pop $GRRR $QUBT

0 · Reply

Yeueehehe Nov. 18 at 5:36 PM

$COCH the only green in my bloody portfolio

0 · Reply

HITK101 Nov. 18 at 5:32 PM

$COCH $LFS getting nice

0 · Reply

makedatbread88 Nov. 18 at 5:22 PM

$COCH watching closely here

0 · Reply

newsfile_corp Nov. 18 at 1:01 PM

https://nfne.ws/274799 $COCH @envoymedical #Chemicals #Biotechnology #HealthCare #NASDAQ #Investing

0 · Reply

Market Cap	19.67M
Revenue (ttm)	230,000.00
Net Income (ttm)	-20.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-9,043.48%
Debt to Equity Ratio	-0.94

Volume	212,000
Avg Vol	3,653,262
Day's Range	N/A - N/A
Shares Out	25.67M
Stochastic %K	44%
Beta	2.09
Analysts	Strong Sell
Price Target	$7.50